08/28/2024
3:31 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
12:16 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
10:35 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:38 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:04 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
9:54 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
4:35 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/17/2024
4:14 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:38 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:28 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
9:28 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
5:04 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:10 PM | Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
12:07 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
3:32 PM | Crinetics Pharmaceuticals (Issuer)
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:31 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:32 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:03 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
10:01 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
5:07 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
4:08 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:24 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:45 PM | Crinetics Pharmaceuticals (Filer)
| Form S-3ASR | |
06/21/2024
3:31 PM | Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:35 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
10:55 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
12:44 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
7:23 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
5:29 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
4:23 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:36 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:09 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why billionaires are wiring money to abandoned towns (Ad) A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.  Click here for my exclusive video |
04/04/2024
3:17 PM | Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:31 PM | Crinetics Pharmaceuticals (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
1:34 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
4:20 PM | Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
5:31 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:32 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:33 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:34 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:35 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:36 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:37 PM | Crinetics Pharmaceuticals (Subject)
Fust Matthew K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:40 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2024
2:34 PM | Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024
7:18 PM | Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:59 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:01 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:01 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:57 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:05 PM | Crinetics Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024
3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024
3:31 PM | Crinetics Pharmaceuticals (Subject)
Krasner Alan Seth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
5:36 PM | Crinetics Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:54 AM | Crinetics Pharmaceuticals (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:50 AM | Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
01/26/2024
4:50 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
9:28 AM | Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/12/2024
3:12 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
11:10 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:03 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:43 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:45 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:44 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
4:20 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
10:47 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:45 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:28 PM | Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:37 PM | Crinetics Pharmaceuticals (Subject)
Krasner Alan Seth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:44 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
12:48 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
3:31 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
10:40 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
3:33 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:31 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2023
5:02 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:38 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
11/01/2023
3:44 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
4:01 PM | Crinetics Pharmaceuticals (Issuer)
Krasner Alan Seth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:20 PM | Crinetics Pharmaceuticals (Subject)
Krasner Alan Seth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:24 PM | Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
09/13/2023
4:19 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/13/2023
4:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
3:09 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2023
5:05 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
